⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AKRO News
Braveheart Bio Announces Senior Leadership Appointments to Strengthen Scientific and Operational Capabilities While Advancing Global Phase 3 Development
prnewswire.com
AKRO
GILD
MYO
GMP Cytokine Market and Competition Outlook to 2031: Growing at 8.4% CAGR, Led by Bio-Techne, PeproTech, CellGenix Among Others - ResearchAndMarkets.com
businesswire.com
TECH
PEP
CGNX
LZ
AKRO
CRBP
Novo Nordisk has completed its acquisition of Akero Therapeutics
globenewswire.com
AKRO
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO
businesswire.com
AKRO
NASH/MASH Treatment Market to Surpass USD 31.76 Billion by 2033 as First-in-Class Drugs Redefine Fatty Liver Disease Management | According to DataM Intelligence
prnewswire.com
MDGL
AKRO
BTRX
SAGM
Halper Sadeh LLC Encourages WOW, AKRO, HFWA, BRY Shareholders to Contact the Firm to Discuss Their Rights
prnewswire.com
WOW
AKRO
HFWA
BRY
Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights
prnewswire.com
NIC
AKRO
BRNS
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting® 2025
globenewswire.com
AKRO
Halper Sadeh LLC Encourages AKRO, CADE, FSUN Shareholders to Contact the Firm to Discuss Their Rights
prnewswire.com
AKRO
CADE
FSUN
Halper Sadeh LLC Encourages FFWM, AKRO, CCRD Shareholders to Contact the Firm to Discuss Their Rights
prnewswire.com
FFWM
AKRO
CCRD